Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement
- PMID: 15800115
- DOI: 10.1681/ASN.2005010086
Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement
Abstract
Thrombotic thrombocytopenic purpura is a rare disorder of small vessels that is associated with deficiency of the von Willebrand factor-cleaving protease ADAMTS13, which favors platelet adhesion and aggregation in the microcirculation. The disease manifests mainly with central nervous system symptoms, but cases of renal insufficiency have been reported. Presented are findings of the genetic basis of phenotype heterogeneity in thrombotic thrombocytopenic purpura in two sisters within one family. The patients had ADAMTS13 deficiency as a result of two heterozygous mutations (causing V88M and G1239V changes). In addition, a heterozygous mutation (causing an S890I change) in factor H of complement was found in the patient who developed chronic renal failure but not in her sister, who presented with exclusive neurologic symptoms.
Similar articles
-
[From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].Ned Tijdschr Geneeskd. 2003 Dec 6;147(49):2422-4. Ned Tijdschr Geneeskd. 2003. PMID: 14694551 Review. Dutch.
-
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.N Engl J Med. 1998 Nov 26;339(22):1578-84. doi: 10.1056/NEJM199811263392202. N Engl J Med. 1998. PMID: 9828245
-
von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.Blood. 2003 Mar 1;101(5):1845-50. doi: 10.1182/blood-2002-08-2399. Epub 2002 Oct 17. Blood. 2003. PMID: 12393505
-
ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.Br J Haematol. 2003 Mar;120(5):821-4. doi: 10.1046/j.1365-2141.2003.04183.x. Br J Haematol. 2003. PMID: 12614216
-
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.Int J Hematol. 2002 Aug;76 Suppl 2:132-8. Int J Hematol. 2002. PMID: 12430913 Review.
Cited by
-
Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.Blood. 2013 Aug 22;122(8):1487-93. doi: 10.1182/blood-2013-03-492421. Epub 2013 Jul 11. Blood. 2013. PMID: 23847193 Free PMC article.
-
Optimal management of atypical hemolytic uremic disease: challenges and solutions.Int J Nephrol Renovasc Dis. 2019 Sep 4;12:183-204. doi: 10.2147/IJNRD.S215370. eCollection 2019. Int J Nephrol Renovasc Dis. 2019. PMID: 31564951 Free PMC article.
-
ADAMTS13 and microvascular thrombosis.Expert Rev Cardiovasc Ther. 2006 Nov;4(6):813-25. doi: 10.1586/14779072.4.6.813. Expert Rev Cardiovasc Ther. 2006. PMID: 17173498 Free PMC article. Review.
-
The kidney in thrombotic thrombocytopenic purpura.Minerva Med. 2007 Dec;98(6):731-47. Minerva Med. 2007. PMID: 18299685 Free PMC article. Review.
-
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura.Expert Rev Hematol. 2024 Jul;17(7):341-351. doi: 10.1080/17474086.2024.2356763. Epub 2024 May 20. Expert Rev Hematol. 2024. PMID: 38752747 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous